Shanghai RASS-Safety,Quality,Efficacy

  • a1_banpc01_1.jpg 2-245.jpg
    Safety,Quality,Efficacy
  • a1_banpc01_3-191.jpg 3.jpg
    Safety,Quality,Efficacy
  • banner-3-1.jpg banner-3-2.jpg
    Safety,Quality,Efficacy
  • banner-1.jpg banner-1-2.jpg
    Safety,Quality,Efficacy
beijing.jpg chanpinzhongxin.jpg
a1_banpc04.jpg xinwenzhongxin.jpg
a1_banpc05.jpg guanyulaishi.jpg

About RAAS

Being vital for life saving, blood products are important national strategic reserve materials. Founded in 1988 and situated at No. 2009 Wangyuan Road, Fengxian District, Shanghai with a registered capital of RMB 6,740,787,907.00, Shanghai RAAS was listed on the Shenzhen Stock Exchange in June 2008 as a leading domestic blood products company that integrates source plasma collection, blood products research and development, production and sales.

  • 36 years
    Extensive industry experience
  • 5 units
    Production Bases
  • 44 centers
    Plasma Donation Center
Yuan +0.20 (+3.13%)
Stock Code:
a1_banpc06.jpg laishijiangzhan.jpg

RAAS Plasma Donation Center

As of Dec 2023, Shanghai RAAS and its subsidiaries had 44 plasma donation centers (including newly approved ) in China including those under construction, of which 18 are Shanghai RAAS , 19 are Tonrol Biopharmaceutical, 2 are Zhengzhou RAAS,3 are Zhejiang Haikang Biopharmaceutical and 2 are GuangXi RAAS, covering 11 provinces (autonomous regions) in Guangxi, Hunan, Hainan, Shaanxi, Anhui, Guangdong, Inner Mongolia, Zhejiang, Hubei, Jiangxi and Shandong.

  • 18 centers
    Shanghai RAAS (including one subcenter)
  • 19 centers
    Tonrol Biopharmaceutical
  • 2 centers
    Zhengzhou RAAS
  • 3 centers
    Zhejiang Haikang Biopharmaceutical
  • 2 centers
    GuangXi RAAS
a1_ditu1.svg